Rejected at 2:14 a.m. Nov, 01, 2023 ] by Ahmed7
Author: skstroh
Related Note: 1497203670771
Rationale for change

removed UW tag that didnt match

Rejection reason

comment

Text
Eculizumab is a monoclonal antibody for the {{c1::C5}} complement protein
Extra
- C5 is an important step in generating the membrane attack complex (MAC), formed of C5b + C6-C9
- Used to treat paroxysmal nocturnal hemoglobinuria
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy
Empty field
Sketchy 2

Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Empty field
Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Transplant Rejection: Biologic Immunotherapy
OME

Additional Resources
Empty field
One by one
Empty field
Changed Tags
#AK_Step1_v12::#UWorld::18594
#AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::01_Autoimmune_disease_therapy::*Eculizumab #AK_Step2_v12::#SketchyPeds::07_Nephrology_&_Urology::02_Infectious_&_Sequelae::01_Hemolytic_Uremic_Syndrome #AK_Step1_v12::#UWorld::Step::18594 #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::^Other::^HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Immunology::13_Transplant_Rejection::08_Biologic_Immunotherapy #AK_Step1_v12::#B&B::11_Hematology::02_Red_Blood_Cells::03_Intrinsic_Hemolysis #AK_Step1_v12::#SketchyPharm::Immunology-&-Biochemistry-Pharmacology::Immuno-suppressives::General-Immunotherapy !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#UWorld::COMLEX::26697 #AK_Step1_v12::^Other::^EXPN #AK_Step2_v12::#B&B::07_Hematology_and_Oncology::01_Red_Cells::06_Intrinsic_Hemolysis #AK_Step1_v12::#OME::PreClinical::Immunology